Literature DB >> 16227426

Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.

S N Nikas, P V Voulgari, I P Takalou, P Katsimbri, A A Drosos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16227426      PMCID： PMC1755277          DOI： 10.1136/ard.2005.036178

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Development of new-onset psoriasis while on anti-TNFalpha treatment.

Authors:  C Matthews; S Rogers; O FitzGerald
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

2.  Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience.

Authors:  Paraskevi V Voulgari; Aliki I Venetsanopoulou; Efstratios K Epagelis; Yannis Alamanos; Ioanna Takalou; Alexandros A Drosos
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

3.  A Case of Recalcitrant Psoriatic Arthritis to TNF Inhibitors Improved After Administration of Secukinumab, an IL-17A Inhibitor.

Authors:  Eleftherios Pelechas; Tereza Memi; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Rheumatol Ther       Date:  2017-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.